drugset / Trial / NCT03376737
Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to confirm the safety and efficacy of Apatinib plus Pemetrexed as the Maintenance Therapy in Advanced Lung Adenocarcinoma.
Timeline
- Start
- 2017-10-12
- Primary completion
- 2018-06
- Completion
- 2019-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pemetrexed | Small molecule | 500 mg/m2 | — |
| Subject | Rivoceranib | Small molecule | 250 mg | — |